2024-07-18 07:31:16 ET
More on Abbott Laboratories
- Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough
- Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price
- Abbott Laboratories: Why I Agree With Wall Street On This One
- Abbott Q2 Earnings Preview: Strong fundamentals to see through a good quarter
- Abbott receives FDA clearance for new continuous glucose monitoring systems
Read the full article on Seeking Alpha
For further details see:
Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.4B beats by $30M